FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589825964> ?p ?o ?g. }

• W2589825964 endingPage "70" @default.
• W2589825964 startingPage "70" @default.
• W2589825964 abstract "70 Background: Metastatic breast cancer (MBC) and its treatments can have a significant impact on patients’ health-related quality of life (HRQoL) and daily functioning. To better assess the impact of MBC on HRQoL, we conducted an online survey among women with MBC. Methods: We developed and administered a cross-sectional, web-based survey, and invited registered members of three advocacy groups currently living with MBC to participate. Respondents completed an informed consent and completed assessments on symptom burden using an overall QOL question (1 item), the MD Anderson Symptom Inventory Survey (MDASI), activities of daily living (ADLs, Rotterdam Scale), and impacts on work productivity. Results: We received 1285 complete responses to the survey. Over half the respondents were between 40-49yrs (37%) or 30-39 yrs (26%). The majority were white (87.7%), well-educated (70.7% had a bachelor’s degree or higher), and working at the time of the survey (55%), with private health insurance (63%). After diagnosis with MBC, most patients had received endocrine therapy (44.2% aromatase inhibitors, 27.3% fulvestrant). The most common chemotherapy agents received after diagnosis with MBC were capecitabine (30.1%) and docetaxel (26.9%). The overall mean HRQoL score was 74 (0-100, higher is better). Mean respondent-reported MDASI scores for symptom severity (SS) and symptom interference (SI) were 4.2 and 4.5 (0-10, higher is worse). Mean Rotterdam scale scores to assess ADLs were 23.7 (0-32, higher better). On average, working women with MBC missed 9.3 hours of work in the past 7 days due to their MBC. As symptom burden increased, respondents reported a lower ability to perform ADLs (p < 0.0001) and lower overall HRQoL (p < 0.0001). The ability to perform ADLs decreased with increase in the total number of agents received (p < 0.0001) and time since diagnosis (p < 0.0001). Conclusions: This survey provides valuable insights into health status, ability to perform ADLs, and lost productivity among patients with MBC. Future analyses will present results by tumor subtypes and drug treatments received." @default.
• W2589825964 created "2017-03-03" @default.
• W2589825964 creator A5004104262 @default.
• W2589825964 creator A5028764986 @default.
• W2589825964 creator A5043382534 @default.
• W2589825964 creator A5051278857 @default.
• W2589825964 creator A5066111898 @default.
• W2589825964 creator A5072015843 @default.
• W2589825964 creator A5084695166 @default.
• W2589825964 date "2016-03-01" @default.
• W2589825964 modified "2023-09-25" @default.
• W2589825964 title "What is the health-related quality of life for women with metastatic breast cancer?" @default.
• W2589825964 doi "https://doi.org/10.1200/jco.2016.34.7_suppl.70" @default.
• W2589825964 hasPublicationYear "2016" @default.
• W2589825964 type Work @default.
• W2589825964 sameAs 2589825964 @default.
• W2589825964 citedByCount "0" @default.
• W2589825964 crossrefType "journal-article" @default.
• W2589825964 hasAuthorship W2589825964A5004104262 @default.
• W2589825964 hasAuthorship W2589825964A5028764986 @default.
• W2589825964 hasAuthorship W2589825964A5043382534 @default.
• W2589825964 hasAuthorship W2589825964A5051278857 @default.
• W2589825964 hasAuthorship W2589825964A5066111898 @default.
• W2589825964 hasAuthorship W2589825964A5072015843 @default.
• W2589825964 hasAuthorship W2589825964A5084695166 @default.
• W2589825964 hasConcept C121608353 @default.
• W2589825964 hasConcept C126322002 @default.
• W2589825964 hasConcept C159110408 @default.
• W2589825964 hasConcept C1862650 @default.
• W2589825964 hasConcept C2775930923 @default.
• W2589825964 hasConcept C2779951463 @default.
• W2589825964 hasConcept C512399662 @default.
• W2589825964 hasConcept C530470458 @default.
• W2589825964 hasConcept C71924100 @default.
• W2589825964 hasConcept C74909509 @default.
• W2589825964 hasConcept C79544238 @default.
• W2589825964 hasConceptScore W2589825964C121608353 @default.
• W2589825964 hasConceptScore W2589825964C126322002 @default.
• W2589825964 hasConceptScore W2589825964C159110408 @default.
• W2589825964 hasConceptScore W2589825964C1862650 @default.
• W2589825964 hasConceptScore W2589825964C2775930923 @default.
• W2589825964 hasConceptScore W2589825964C2779951463 @default.
• W2589825964 hasConceptScore W2589825964C512399662 @default.
• W2589825964 hasConceptScore W2589825964C530470458 @default.
• W2589825964 hasConceptScore W2589825964C71924100 @default.
• W2589825964 hasConceptScore W2589825964C74909509 @default.
• W2589825964 hasConceptScore W2589825964C79544238 @default.
• W2589825964 hasIssue "7_suppl" @default.
• W2589825964 hasLocation W25898259641 @default.
• W2589825964 hasOpenAccess W2589825964 @default.
• W2589825964 hasPrimaryLocation W25898259641 @default.
• W2589825964 hasRelatedWork W1510266025 @default.
• W2589825964 hasRelatedWork W1966679288 @default.
• W2589825964 hasRelatedWork W2057036475 @default.
• W2589825964 hasRelatedWork W2078258706 @default.
• W2589825964 hasRelatedWork W2167725609 @default.
• W2589825964 hasRelatedWork W2195671413 @default.
• W2589825964 hasRelatedWork W2276162241 @default.
• W2589825964 hasRelatedWork W2425184916 @default.
• W2589825964 hasRelatedWork W2888487974 @default.
• W2589825964 hasRelatedWork W134920489 @default.
• W2589825964 hasVolume "34" @default.
• W2589825964 isParatext "false" @default.
• W2589825964 isRetracted "false" @default.
• W2589825964 magId "2589825964" @default.
• W2589825964 workType "article" @default.